In This Section

Program

Please note that this meeting will take place as an in-person event in San Diego and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

Thursday, January 14

FRIDAY, JANUARY 15

SATURDAY, JANUARY 16

SUNDAY, JANUARY 17

Thursday, January 14

REGISTRATION

4-8 p.m.

WELCOME AND OPENING Keynote

5:30-6:10 p.m.

  • 5:30 p.m. | Welcome and Introduction
  • 5:35 p.m. | Opening Keynote Address
    Charles Swanton, The Francis Crick Institute, London, United Kingdom

Plenary Session 1: Prevention, Risk, Early Detection, and Screening

6:10–7:45 p.m.

  • Christine D. Berg, NCI, Bethesda, MD (retired)
  • David R. Baldwin, Nottingham University Hospitals, Nottingham, United Kingdom
  • Pan-Chyr Yang, National Taiwan University College of Medicine, Taipei, Taiwan

OPENING RECEPTION

7:45-9 p.m.

Friday, January 15

CONTINENTAL BREAKFAST AND Career Development Roundtable PROFESSIONAL

7-8 a.m.

Plenary Session 2: MRD and Adjuvant Disease—Resectable NSCLC Beyond Neoadjuvant Therapy

8–9:55 a.m.

  • Christine M. Lovly, City of Hope, Duarte, California
  • Maximillian Diehn, Stanford University, Stanford, California
  • Patrick Forde, Johns Hopkins University, Baltimore, MD and Trinity College Dublin, Dublin, Ireland

Break

9:55-10:20 a.m.

Plenary Session 3: Innovations in Trial Design

10:20-11:55 a.m.

  • Annie Chiang, Yale University, New Haven, Connecticut
  • Benjamin Besse, Institut Gustave Roussy, Paris, France
  • Thomas U. Marron, Icahn School of Medicine at Mount Sinai, New York, New York

Lunch (on your own)

11:55 a.m–1:30 p.m.

Plenary Session 4: Small Cell Lung Cancer I—Basic Mechanisms to Translational Advances

1:30-3:05 p.m.

  • Trudy G. Oliver, Duke University, Durham, North Carolina
  • Matthew G. Oser, Dana‑Farber Cancer Institute, Boston, Massachussetts
  • Julien Sage, Stanford University, Stanford, California

Break

3:05–3:20 p.m.

Plenary Session 5: Small Cell Lung Cancer II—Clinical Advances and Emerging Therapies

3:20-4:55 p.m.

  • Charles M. Rudin, Memorial Sloan Kettering Cancer Center, New York, New York
  • Anna Farago, Amgen, Thousand Oaks, California
  • Caroline Dive, CRUK, Manchester, United Kingdom

Break

4:55-5:10 p.m.

Plenary Session 6: Oncogene‑Driven Lung Cancer—From Biology to Treatment

5:10-6:45 p.m.

  • Katerina A. Politi, Yale Cancer Center, New Haven, Connecticut
  • Monte M. Winslow, Stanford University, Stanford, California

Lightning Talks (Session A)

6:45-7 p.m.

Poster Session A/Reception

7-9 p.m.

Saturday, January 16

CONTINENTAL BREAKFAST AND Career Development Roundtable PROFESSIONAL

7-8 a.m.

Keynote Address 2

8-8:35 a.m.

  • Miriam Merad, Icahn School of Medicine at Mount Sinai, New York, New York

Plenary Session 7: Immuno‑Oncology—Mechanisms, Resistance, Combinations

8:35-10:10 a.m.

  • Elizabeth M. Jaffee, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
  • Tina Cascone, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Ramaswamy Govindan, Washington University School of Medicine in St. Louis, St. Louis, Missouri

Break

10:10-10:25 a.m.

Plenary Session 8: Next‑Generation Novel Therapeutics in Lung Cancer

10:25 a.m.-12 p.m.

  • Adrian G. Sacher, UHN Princess Margaret Cancer Centre, Toronto, Canada
  • Daniel S. W. Tan, National Cancer Centre Singapore, Singapore
  • Timothy A. Yap, The University of Texas MD Anderson Cancer Center, Houston, Texas

Lunch (on your own)

12-1:45 p.m.

Plenary Session 9: Squamous and Smoker‑Associated Lung Cancers—Biology to Clinic

1:45-3:15 p.m.

  • Jianjun ‘Jay’ Zhang, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Michael Ben Major, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  • Kathryn A. O’Donnell, UT Southwestern, Dallas, Texas

Break

3:15-3:30 p.m.

Plenary Session 10: New Frontiers in Lung Cancer Biology & Therapeutics

3:30-5 p.m.

  • Leanne Li, The Francis Crick Institute, London, United Kingdom
  • Tuomas Tammela, Memorial Sloan Kettering Cancer Center, New York, New York
  • Humam Kadara, The University of Texas MD Anderson Cancer Center, Houston, Texas

Lightning Talks (Session B)

5-5:30 p.m.

Poster Session B / Reception

5:30-7:30 p.m.

Sunday, January 17

CONTINENTAL BREAKFAST

7-8 a.m.

Keynote Address 3

8-8:35 a.m.

  • Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong

Plenary Session 11: Tumor Biology & Metabolism

8:35-10:10 a.m.

  • Gina M. DeNicola, Moffitt Cancer Center, Tampa, Florida
  • Reuben Shaw, The Salk Institute for Biological Studies, La Jolla, California

Break

10:10-10:30 a.m.

Plenary Session 12: Emerging Technologies—Spatial, Functional Genomics, Theranostics and AI

10:30 a.m. – 12:05 p.m.

  • Regina Barzilay, MIT, Cambridge, Massachusetts
  • Hugo Aerts, MIT, Cambridge, Massachusetts
  • Christina Curtis, Stanford University, Stanford, California

Closing Remarks

12:05 p.m.